In an earlier study, ZFPM2-AS1 was demonstrated to participate in the occurrence and development of gastric cancer and was positively correlated with depth of tumor invasion, differentiation grade, tumor size, N stage, and TNM stage, suggesting that ZFPM2-AS1 is a potential diagnostic biomarker and/or therapeutic target for gastric cancer. This evidence concerns the gene ZFPM2 and gastric cancer.